APA (7th ed.) Citation

M, C., S, B., K, R., JR, F., SM, D., S, R., . . . PB, D. (2026). Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: Incidence, risk factors, and clinical impact. Bone marrow transplantation, 61(2), 142. https://doi.org/10.1038/s41409-025-02745-5

Chicago Style (17th ed.) Citation

M, Corona, et al. "Late Hematologic Toxicity After CAR T-cell Therapy in Large B-cell Lymphoma: Incidence, Risk Factors, and Clinical Impact." Bone Marrow Transplantation 61, no. 2 (2026): 142. https://doi.org/10.1038/s41409-025-02745-5.

MLA (9th ed.) Citation

M, Corona, et al. "Late Hematologic Toxicity After CAR T-cell Therapy in Large B-cell Lymphoma: Incidence, Risk Factors, and Clinical Impact." Bone Marrow Transplantation, vol. 61, no. 2, 2026, p. 142, https://doi.org/10.1038/s41409-025-02745-5.